Encora Therapeutics

Encora is working on building affordable, non-invasive neurostimulation devices for those affected by movement disorders, including Parkinsons. The wearables work by sensing, then counteracting a patients motor symptoms via customized vibratory stimulation to the wrist. Last week, Encora got a major boost in the form of $1.5 million in pre-seed funding. The round was led by Innospark Ventures, with participation from Good Growth Capital (GGC), the Technology Accelerator Company and the SDX Holding Company. Encora Therapeutics CEO Daniel Carballo, selected as BostInno&s;s 25 Under 25 They say youre never too old to follow your dreams. Seems that youre never too young, either. Boston teen and college-age technologists and entrepreneurs are living that mantra, founding companies, publishing books and working as venture capitalists without waiting for anyones permission. We looked across the Bay State to find some of todays brightest young mindsand honor them through our annual awards list, 25 Under 25.